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Retinal Degeneration
Abstract
CYCLIC NUCLEOTIDES mediate many aspects of normal cellular metabolism; thus, degradation as well as
synthesis of these intracellular mediators must be strictly regulated. Phosphodiesterase (PDE), the enzyme of
cyclic nucleotide catabolism, is present in mammalian tissues in multiple forms, which differ in substrate
specificity, kinetic characteristics and sub-cellular localisation. Moreover, a calcium-dependent protein
activator (now called calmodulin) has been characterised that specifically activates at least one of the PDE
types although other types of PDE are known to be activator independent. Thus, several mechanisms are
present in vivo which allow strict control of PDE. A unique cyclic GMP-PDE is compartmentalised in the
outer segments of retinal photoreceptor cells; its activity is low in the dark-adapted state but increases
dramatically on light adaptation. The resulting drop in cyclic GMP content could serve as a chemical ‘signal’ in
the normal visual process. However, despite much investigation of various cyclic nucleotide systems, no
definitive information has been obtained which clearly links a disorder of cyclic nucleotide metabolism with a
disease process elsewhere than in retina. We have recently presented preliminary evidence that an abnormality
in cyclic GMP metabolism could be present in the retinas of Irish setter dogs with inherited rod–cone
dysplasia that could lead to greatly increased cyclic GMP content, as had been reported in mice with inherited
retinal degeneration. We now report that the basic defect in the disease seems to be a failure to switch PDE
type and a concomitant decrease in protein activator concentration early in postnatal development, at the
time of photoreceptor differentiation.
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the mean distance between gap junctions linking neighbouring 
L1 units should be greater in the direction parallel to the streak 
than perpendicular to it. Assuming that cytoplasmic resistance is 
much lower than junctional resistance, the signal attenuation 
will occur mainly at these junctions. We further assume a 
uniform distribution of gap junctions along the cell surface. The 
signal attenuation per unit length normal to the slit stimulus will 
then be greater in the direction perpendicular to the streak 
resulting in receptive fields elongated along the streak. 
The mechanism described above is based upon a network of 
L1 units each of which has a common orientation. A random 
distribution of orientations of elongated cells would result in 
more equal mean distances between junctions along any two 
orthogonal directions. This type of anatomical arrangement is in 
fact seen in Golgi-impregnated L1-type horizontal cells in the 
peripheral retina. Here, our preliminary physiological findings 
indicate that L1-type horizontal cells have response eccen-
tricities closer to 1.0 with no consistently observed preferred 
orientation along any particular axis. 
In this paper, we have shown that the streak region of t~e 
turtle retina contains at least one population of cells wtth 
specialised properties; the axonal arborisations and the recep-
tive fields of L1 horizontal cells in this region are elongated in the 
direction of the streak. The functional significance of the speci-
alisations in the streak region may be better understood from 
ganglion cell recordings in this region. However, such 
measurements have only been made in the visual streak of 
another species, the rabbit1 • Amongst rabbit ganglion cells in 
this region, orientation selective units were found which 
responded only to slits of light which were oriented either 
parallel or perpendicular to the streak. _Although a full u?der-
standing of receptive fields at the ganglion cell level requues a 
greater knowledge of signal processing in the inner and outer 
plexiform layers, the oriented horizontal cell receptive fields 
described here may have significance for the development of 
orientation specificity in the visual streaks of species whose 
retinas contain this specialisation. 
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Involvement of cyclic GMP 
phosphodiesterase activator 
in an hereditary retinal degeneration 
CYCLIC NUCLEOTIDES mediate many aspects of normal cellu-
lar metabolism1 ; thus, degradation as well as synthesis of these 
intracellular mediators must be strictly regulated. Phospho-
diesterase (PDE), the enzyme of cyclic nucleotide catabolism, 
is present in mammalian tissues in multiple forms, which 
differ in substrate specificity, kinetic characteristics and sub-
cellular localisation2 • Moreover, a calcium-dependent protein 
activator (now called calmodulin) has been characterised that 
specifically activates at least one of the PDE types3 '4 although 
other types of PDE are known to be activator independent5"6 • 
Thus, several mechanisms are present in vivo which allow strict 
control of PDE. A unique cyclic GMP-PDE is compart-
mentalised in the outer segments of retinal photoreceptor 
cells7- 10 ; its activity is low in the dark-adapted state but increases 
dramatically on light adaptation 10- 12 • The resulting drop in cyclic 
GMP content could serve as a chemical 'signal' in the normal 
visual process13•14 • However, despite much investigation of 
various cyclic nucleotide systems, no definitive information has 
been obtained which clearly links a disorder of cyclic nucleotide 
metabolism with a disease process elsewhere than in retina15"16• 
We have recently presented preliminary evidence that an 
abnormality in cyclic GMP metabolism could be present in the 
Fig. I a, Photoreceptor layer from a 13-d-old normal Irish sette.r. 
Photoreceptor outer segments have begun to elongate and contam 
well organised stacks of outer segment (OS) lamellar disks. Some of 
these seem to have been engulfed (arrow) by the pigment epi-
thelium (PE). b, Photoreceptor layer from a 13-d old affected Irish 
setter. Small photoreceptor inner segments (IS) project through 
the external limiting membrane (ELM). There is minimal outer 
segment material; some is apposed to the PE apex (arrow) and 
some seems to be located within the PE cytoplasm (double arrow) 
xl0,400. 
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Fla. 3 Schematic outline of morphological and biochemical 
events in the development of outer segments (OS) in control and 
affected retinas. In both control and affected retinas, no OS are 
observed in the first postnatal week. OS appear in the second week, 
develop normally (4-5 weeks) in the control retinas but quickly 
degenerate in affected retinas. Biochemically, the cyclic GMP-
PDE enzyme switches from an activator-dependent to an activa-
tor-independent type in control retinas but not in affected retinas. 
Protein activator concentration is substantially decreased in 
affected retinas. 
It is well known that enzyme patterns change during 
developmene3•24 • Recent evidence suggests that, at least in 
some tissues, PDE activity changes during differentiation with 
regard to its sensitivity to regulation by the Ca2+ -dependent 
protein activator25'26• Our data strongly indicate that a normal 
switch in PDE type fails to occur in affected retinas during 
photoreceptor development and that the low level of activator 
present in these retinas may not be sufficient to maintain 
adequate cyclic GMP-PDE activity (Fig. 3).1t seems, therefore, 
that for the first time calmodulin can be directly linked to a 
disease process. It will be interesting to see if a similar situation 
exists in other degenerative diseases or if this biochemical defect 
is unique to inherited degeneration of the neural retina. 
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Evidence that cyclic GMP 
regulates membrane 
potential in rod photoreceptors 
CYCLIC NUCLEOTIDES have been proposed as mediators of 
the decreased Na+ permeability caused by illumination of 
vertebrate photoreceptors1•2 • We show here that cyclic GMP 
depolarises the rod outer segment (ROS) approximately to the 
Na+ equilibrium potential within milliseconds after being 
injected intracellularly, that previous light adaptation 
antagonises this depolarisation, and that the injection of cyclic 
GMP without illumination initiates a repolarisation after a time 
lag which is longer than that following a light flash and propor-
tional to the injection time. The results are interpreted in terms 
of a model in which cyclic GMP levels are controlled by the 
resultant of cyclase and phosphodiesterase (PDE) velocities. 
The PDE velocity of hydrolysis in the dark is increased by prior 
light adaptation in the presence of increased substrate (cyclic 
GMP). The data suggest that cyclic GMP is an important factor 
in the regulation of the membrane potential of the ROS. 
Biochemical experiments on the cyclic nucleotide system of 
isolated homogenised ROS suggest that illumination decreases 
the concentration of cyclic GMP by activating a GTP-dependent 
PDE3.4. The rate of light-initiated hydrolysis of cyclic GMP by 
PDE is apparently sufficiently fast to mediate the rapid initial 
decrease in Na+ permeabilty5•6 • The cyclic GMP that is not 
hydrolysed presumably increases Na+ permeability. The 
mechanism of increased Na+ permeability of the ROS plasma 
membrane would be by phosphorylating a membrane protein6 •7 
as proposed for other tissues. Superfusion with cyclic GMP or a 
PDE inhibitor has been shown to depolarise rods8 • We have 
injected cyclic GMP intracellularly through the recording 
pipette into ROS of the isolated retina of the toad, Bufo 
marinus, to determine the effects of excess cyclic GMP on 
membrane potential, latency and amplitude of the light 
response. We reported9 that this excess cyclic GMP increases 
both the latency and amplitude of the response. Here, using the 
same preparation and methods, we found that excess injected 
cyclic GMP depolarised the rod membrane. This depolarisation 
in dark -adapted preparations frequently exceeded the zero level 
(Figs 1, 2) and attained a maximum value of + 11 mV (Fig. 1a, 
d). A reversal potential of 0 to + 10 mV was obtained for the 
isolated Necturus rod10• A value of + 11 m V implies an intracel-
lular Na+ concentration ([Na+),) of 66 mM, based on our 
extracellular concentration of 103 mM. This compares with 
50 mM [Na+), estimated using another techniqueu. Therefore, 
+ 11 m V seems to approximate to the equilibrium potential for 
Na+. The maximum depolarisation we observe is consistent with 
the interpretation that the injected excess cyclic GMP renders 
the ROS plasma membrane permeable to Na+. 
Intracellular injection of cyclic GMP in the absence of illu-
mination should initiate a recovery from depolarisation after a 
time proportional to the amount injected, provided the dark 
concentration is less than the Km of PDE which is 70 ~tM cyclic 
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